Bradley J. Carver
Amministratore Delegato presso SynDevRx, Inc.
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| James M. Shanahan | M | - |
SynDevRx, Inc.
 SynDevRx, Inc. Miscellaneous Commercial ServicesCommercial Services SynDevRx, Inc. develops treatments for metabolic-related diseases. Its product includes SDX-7320, a polymer conjugate of fumagillol that releases a pharmacologically active small molecule fumagillol derivative in vivo. The company was founded by James M. Shanahan and Bradley J. Carver and is headquartered in Cambridge, MA. | - |
| Richard L. Love | M | 81 |
SynDevRx, Inc.
SynDevRx, Inc. Miscellaneous Commercial ServicesCommercial Services SynDevRx, Inc. develops treatments for metabolic-related diseases. Its product includes SDX-7320, a polymer conjugate of fumagillol that releases a pharmacologically active small molecule fumagillol derivative in vivo. The company was founded by James M. Shanahan and Bradley J. Carver and is headquartered in Cambridge, MA. | - |
| Eric S. Tooker | M | - |
SynDevRx, Inc.
SynDevRx, Inc. Miscellaneous Commercial ServicesCommercial Services SynDevRx, Inc. develops treatments for metabolic-related diseases. Its product includes SDX-7320, a polymer conjugate of fumagillol that releases a pharmacologically active small molecule fumagillol derivative in vivo. The company was founded by James M. Shanahan and Bradley J. Carver and is headquartered in Cambridge, MA. | - |
| Charles Flynn | M | - |
SynDevRx, Inc.
SynDevRx, Inc. Miscellaneous Commercial ServicesCommercial Services SynDevRx, Inc. develops treatments for metabolic-related diseases. Its product includes SDX-7320, a polymer conjugate of fumagillol that releases a pharmacologically active small molecule fumagillol derivative in vivo. The company was founded by James M. Shanahan and Bradley J. Carver and is headquartered in Cambridge, MA. | - |
| Michael Clifford | M | - |
SynDevRx, Inc.
SynDevRx, Inc. Miscellaneous Commercial ServicesCommercial Services SynDevRx, Inc. develops treatments for metabolic-related diseases. Its product includes SDX-7320, a polymer conjugate of fumagillol that releases a pharmacologically active small molecule fumagillol derivative in vivo. The company was founded by James M. Shanahan and Bradley J. Carver and is headquartered in Cambridge, MA. | - |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| John W. Burns | M | 78 |
Glycogenesys, Inc.
 Glycogenesys, Inc. Miscellaneous Commercial ServicesCommercial Services GlycoGenesys, Inc., a biotechnology company, develops novel pharmaceutical products based on carbohydrate compounds and related technologies. The company's lead drug candidate GCS-100, a treatment for various forms of solid tumors and bloodborne cancers, completed a Phase II (a) clinical trial for pancreatic cancer, and also completed a Phase II (a) clinical trial for colorectal cancer. The company focuses on the development of carbohydrate-based pharmaceutical products and related technologies in connection with oncology. It was founded in 1992 and is headquartered in Boston, MA. | - |
| Barry Martin | M | - |
Michigan State University
| 10 anni |
| Richard C. Adloff | M | - |
Michigan State University
| 4 anni |
| David C. Peck | M | - |
Michigan State University
| 6 anni |
| Julie Gorte | M | - |
Michigan State University
| 4 anni |
| Dennis A. Zalupski | M | - |
Michigan State University
| 6 anni |
| Keith M. Swaffar | M | - |
Michigan State University
| 6 anni |
| David Sylvester | M | 59 |
Michigan State University
| 6 anni |
| Steve Stanislaus | M | - |
Michigan State University
| 3 anni |
| Todd Penegor | M | 57 |
Michigan State University
| 6 anni |
| Jeffrey C. Wolf | M | - |
Michigan State University
| 8 anni |
| Donald G. Fortunate | M | - |
Michigan State University
| 10 anni |
| David Cook | M | 61 |
Michigan State University
| 7 anni |
| David W. Dube | M | 68 |
Glycogenesys, Inc.
Glycogenesys, Inc. Miscellaneous Commercial ServicesCommercial Services GlycoGenesys, Inc., a biotechnology company, develops novel pharmaceutical products based on carbohydrate compounds and related technologies. The company's lead drug candidate GCS-100, a treatment for various forms of solid tumors and bloodborne cancers, completed a Phase II (a) clinical trial for pancreatic cancer, and also completed a Phase II (a) clinical trial for colorectal cancer. The company focuses on the development of carbohydrate-based pharmaceutical products and related technologies in connection with oncology. It was founded in 1992 and is headquartered in Boston, MA. | - |
| Judy Wallace | F | - |
Michigan State University
| 4 anni |
| Richard Halprin | M | 59 |
Michigan State University
| 4 anni |
| Daifullah Omar Daifullah Al-Ghamdi | M | 76 |
Michigan State University
| 3 anni |
| Stephen C. Larkin | M | 56 |
Michigan State University
| 4 anni |
| Lynda Knoll Cotter | F | - |
Michigan State University
| 4 anni |
| Judith Fedder | F | 66 |
Michigan State University
| 4 anni |
| Bryan Keith Patmon | M | 65 |
Michigan State University
| 4 anni |
| Paul G. Anthes | M | - |
Michigan State University
| 4 anni |
| Aaron Dent | M | - |
Michigan State University
| 5 anni |
| Rick Sirvatis | M | - |
Michigan State University
| 3 anni |
| Mahmoud Yousuf Jamjoom | M | 64 |
Michigan State University
| 4 anni |
| Gary A. MacDonald | M | - |
Michigan State University
| 4 anni |
| James W. Shelson | M | - |
Michigan State University
| 4 anni |
| Patrick Beirne | M | 61 |
Michigan State University
| 4 anni |
| Robin Hoke | F | - |
Michigan State University
| 4 anni |
| Michael Fusilier | M | - |
Michigan State University
| 4 anni |
| Barbara Metzger | F | - |
Michigan State University
| 4 anni |
| Dan Deming | M | - |
Michigan State University
| 4 anni |
| Carol Hess | F | - |
Michigan State University
| 4 anni |
| Anne Umlauf | F | - |
Michigan State University
| 4 anni |
| Christopher Alvin Bechtel | M | 64 |
Michigan State University
| 4 anni |
| Richard Hunter | M | 62 |
Michigan State University
| 4 anni |
| Kevin Morningstar | M | - |
Michigan State University
| 5 anni |
| John G. Baguley | M | - |
Michigan State University
| 4 anni |
| Bruce Moore | M | - |
Michigan State University
| 4 anni |
| Willie Reed | M | 69 |
Michigan State University
| - |
| James Rolke | M | 55 |
Glycogenesys, Inc.
Glycogenesys, Inc. Miscellaneous Commercial ServicesCommercial Services GlycoGenesys, Inc., a biotechnology company, develops novel pharmaceutical products based on carbohydrate compounds and related technologies. The company's lead drug candidate GCS-100, a treatment for various forms of solid tumors and bloodborne cancers, completed a Phase II (a) clinical trial for pancreatic cancer, and also completed a Phase II (a) clinical trial for colorectal cancer. The company focuses on the development of carbohydrate-based pharmaceutical products and related technologies in connection with oncology. It was founded in 1992 and is headquartered in Boston, MA. | 3 anni |
| Judy M. McNamara | M | - |
Michigan State University
| 3 anni |
| Richard Marshall | M | - |
Michigan State University
| 4 anni |
| John W. Heinricy | M | 76 |
Michigan State University
| 2 anni |
| Pat Albright | M | - |
Michigan State University
| 4 anni |
| Mike King | M | - |
Michigan State University
| 4 anni |
| John R. Kerschen | M | - |
Michigan State University
| 4 anni |
| Glenn Alan Movish | M | - |
Michigan State University
| 4 anni |
| Zhong Ru Gan | M | 76 |
Michigan State University
| 4 anni |
| Rohit Khattar | M | 61 |
Michigan State University
| 4 anni |
| Douglas Darling | M | - |
Michigan State University
| 4 anni |
| Steven W. Wendt | M | - |
Michigan State University
| 4 anni |
| Donald G. Coffey | M | 69 |
Michigan State University
| 3 anni |
| Nicholas L. Blauwiekel | M | 68 |
Michigan State University
| 4 anni |
| James Greenwell | M | 64 |
Michigan State University
| 4 anni |
| Ilya Raskin | M | - |
Michigan State University
| 2 anni |
| Stacy Seng | F | 60 |
Michigan State University
| 4 anni |
| Daniel Doyle | M | 66 |
Michigan State University
| 4 anni |
| Tom Gores | M | 60 |
Michigan State University
| 4 anni |
| Gregory E. Lichtwardt | M | 69 |
Michigan State University
| 2 anni |
| Craig Rogerson | M | 67 |
Michigan State University
| 4 anni |
| Joe Gatz | M | - |
Michigan State University
| 4 anni |
| Timothy Wiggins | M | 68 |
Michigan State University
| 4 anni |
| Brian S. Beattie | M | - |
Michigan State University
| 4 anni |
| Claudia Babiarz | F | - |
Michigan State University
| 3 anni |
| Kevin J. van Solkema | M | 63 |
Michigan State University
| 2 anni |
| Beth O'Shaughnessy | F | 62 |
Michigan State University
| 4 anni |
| Linda Hubbard | F | 64 |
Michigan State University
| 4 anni |
| Jeffrey S. Cartwright | M | - |
Michigan State University
| 4 anni |
| Michael Popielec | M | 62 |
Michigan State University
| 4 anni |
| David G. Mengebier | M | 66 |
Michigan State University
| 4 anni |
| Gregory N. Bakeman | M | 69 |
Michigan State University
| 4 anni |
| David George Gabriel | M | 66 |
Michigan State University
| 4 anni |
| Thomas N. Davidson | M | 64 |
Michigan State University
| 4 anni |
| Brian D. Lewandowski | M | - |
Michigan State University
| 4 anni |
| Christopher Golec | M | - |
Michigan State University
| 4 anni |
| Peter S. Carlson | M | - |
Michigan State University
| 7 anni |
| Burhanuddin Abdullah | M | 77 |
Michigan State University
| 1 anni |
| Richard E. Wills | M | - |
Michigan State University
| 4 anni |
| Sanford B. Cohen | M | 67 |
Michigan State University
| 4 anni |
| Jayme Kurtyka | M | - |
Michigan State University
| 4 anni |
| Bruce Crandall | M | - |
Michigan State University
| 4 anni |
| Larry Negrich | M | - |
Michigan State University
| 4 anni |
| Michael Lingo | M | - |
Michigan State University
| 4 anni |
| Arun Sinha | M | - |
Michigan State University
| 2 anni |
| John Kanellitsas | M | 62 |
Michigan State University
| 4 anni |
| Howard Becker | M | 63 |
Michigan State University
| 3 anni |
| Christopher G. DeClaire | M | 64 |
Michigan State University
| 4 anni |
| Scott William Wagasky | M | - |
Michigan State University
| 3 anni |
| Paul McLean | M | - |
Michigan State University
| 4 anni |
| Jeffrey S. Treasure | M | - |
Michigan State University
| 4 anni |
| Pat D'Eramo | M | 61 |
Michigan State University
| 4 anni |
| George P. Dunn | M | 67 |
Michigan State University
| 4 anni |
| Janice Stipp | F | 64 |
Michigan State University
| 4 anni |
| Mike Klaus | M | 67 |
Michigan State University
| 4 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 100 | 100.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Bradley J. Carver
- Contatti personali
